cieTrade Launches Dumpster and Equipment Rental Solution
Article content
New solution expands cloud platform capabilities to support dumpster and short-term rental businesses
Article content
NORWALK, Conn. — cieTrade, a leading provider of business management software for recycling companies and scrap brokers, announces the launch of its new Dumpster and Equipment Rental Solution, extending its existing cloud platform to serve the needs of dumpster and equipment rental brokers. This new module was designed to address the specific needs of waste equipment rental operations including support for unique processes and workflows, hauler agreements, equipment tracking, service provider logistics, scheduling, automated billing and credit card payment processing and profitability reporting.
Article content
Article content
According to David Haber, founder and principal at cieTrade, 'Many prospective and current clients, otherwise engaged with waste brokerage or recycling, have long expressed an interest in having a dedicated dumpster and equipment rental solution built directly into the cieTrade platform. With the introduction of this module, clients can now avoid workarounds and multiple silos, consolidate operations and improve scalability while obtaining more value from using our platform.'
Article content
Highlights of cieTrade's Dumpster and Equipment Rental Solution:
Article content
Centralized Tickets for Total Control
Each rental service is assigned a ticket number that consolidates all job details— including pickups, drop-offs, service requests and financials— eliminating fragmented workflows and reducing the risk of errors. A visual calendar dashboard prevents scheduling conflicts and double-booking, while automated customer reminders via text and email help reduce delays and improve service reliability.
Real-Time Profitability and Seamless Billing
Integrated billing and credit card processing allows businesses to effectively manage customer accounts, while automating payment processing. Third-party hauler payables are managed in consolidation with expense accruals, making it easy to reconcile invoices, avoid double and over billing and provide timely vendor payments. Gross profit visibility enables businesses to view rental agreement profitability before confirmed bookings, helping to protect margins and ensure smarter decision-making.
Smart Pricing and Relationship Management
Uploading hauler agreements makes on-the-fly pricing during customer calls fast and accurate. Users can also track commissions per ticket, streamlining end-of-month payouts and simplifying rep performance management.
Article content
The Equipment Rental Solution is now available to existing cieTrade cloud platform clients.
Article content
To learn more about cieTrade's Dumpster and Equipment Rental solution and its full suite of business management tools, call (203) 323-0074 or visit www.cietrade.com.
Article content
cieTrade is used by many of the leading recycling and scrap brokers worldwide. They offer a unique business management solution for both (SaaS) cloud and on-premise environments tailored to the needs of bulk commodity traders, recycling plants, pulp and paper companies. Their solution provides the specialized workflows, business processes, shipping documents and financial reports that clients need combined with a support team that offers deep industry knowledge and best practices to help achieve maximum value from the platform.
Article content
Article content
Article content
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
National Post
36 minutes ago
- National Post
Samsara Announces 2025 North America Customer Advisory Board to Accelerate AI-Powered Safety and Efficiency Breakthroughs
Article content Members play a pivotal role in shaping Samsara solutions; meeting to be held today at the premier event for physical operations, Samsara Beyond Article content SAN DIEGO — Samsara Inc. ('Samsara') (NYSE: IOT), the pioneer of the Connected Operations ® Platform, today announced its 2025 North America Customer Advisory Board. Its members are at the forefront of the world's most complex operations, managing vast frontline workforces and asset portfolios, and are responsible for significant economic value. Recognizing the transformative impact of Samsara's AI-powered platform, these leaders have joined forces to help shape Samsara's product roadmap and to exchange insights for safer, more efficient, and sustainable operations for all. Article content 'I've seen firsthand the impact Samsara's platform has made on the industry, and I'm excited to play a role in what's to come,' said Jeff Wright, Vice President of Transportation at Quikrete. 'At Quikrete, we manage complex operations that greatly benefit from Samsara's real-time data. With AI's potential only growing in operations, this is an important moment to partner and drive innovation.' Article content The distinguished members of Samsara's 2025 North America Customer Advisory Board include leaders from organizations such as: Article content ArcBest, Don Davis, Vice President, Fleet Services Artera, Adam Lanier, Chief Safety Officer AWP Safety, Jarrod Wachter, Chief Operating Officer BNSF Railway, Matthew Igoe, Executive Vice President, Operations DHL Express, Fred Matthews, Senior Project Manager, Safety Programs DHL Supply Chain, Jennifer Miller, Vice President, Integrated Transportation Estes, Todd Florence, Chief Information Officer Ferrellgas, Tamria Zertuche, President and Chief Executive Officer First Student, Sean McCormack, Chief Information Officer Frontier Communications, Doug Spurlin, Senior Director, Operations Liberty Energy, Michael Tuomi, Director, HSE and Training MacAllister, Bill Dollard, Director, Corporate Fleet Martin Marietta, Greg Lahrman, Vice President, Enterprise Excellence Maxim Crane Works, Dennis Collins, Vice President, Operations Mohawk Industries, Andy Yearout, Senior Vice President, Supply Chain NiSource, Bill Jefferson, Chief Operations Officer Nutrien Ag Solutions, Adam Lorenz, Senior Director, Fleet and Procurement Operations Performance Food Group, Thomas Olitsky, Vice President, Safety Pike, James Banner, Senior Vice President, Administration and Safety Primoris, Eric Amlee, Vice President, Fleet Operations PS Logistics, Mauricio Paredes, Vice President, Technology Quikrete, Jeff Wright, Vice President, Transportation Republic Services, Brett Rogers, Vice President, Operations Technology Saia, Rohit Lal, Executive Vice President and Chief Information Officer Southeastern Freight Lines, Kerry Stritt, Vice President, Fleet Services Southern California Edison, Karan Kumar, Director, Transportation Services Sysco, Kevin Thomas, Vice President, Global EHSS and Asset Protection Tyson Foods, Phil Vanhook, Managing Director, Transportation Operations UNFI, Tehzin Chadwick, Senior Vice President, Safety UniFirst, Matt Croatti, Senior Vice President, Operations Univar Solutions, Rob McRae, Vice President, Transportation USIC, Tom Karnowski, Vice President, EHS XPO, Greg Pawelski, Vice President, Health and Safety Article content Samsara's platform is advanced by the direct input of its Customer Advisory Board, ensuring its products meet the evolving needs of physical operations. Leaders' insights have shaped innovations like Recognition, a feature that uses AI insights and real-time driver data to identify and celebrate outcomes like safe driving streaks and consistent compliance with regulations. In addition, they've influenced the Asset Tag, a small ruggedized tracker that helps customers find lost or stolen assets, reduce downtime, and streamline inventory management. Article content 'Being on Samsara's Customer Advisory Board has been incredibly valuable because we get to collaborate with other industry leaders and quickly see the results of our product feedback,' said James Banner, Senior Vice President of Administration and Safety at Pike. 'It's a unique opportunity to shape products that transform the way we operate. The Asset Tag is a prime example: we advised on use cases and the product has now reduced theft and improved efficiency for Pike and many others.' Article content Samsara's commitment to building market-leading technology and fostering a collaborative community is foundational to its mission. Its Customer Advisory Board is just one example that demonstrates this, others include Samsara User Groups, Samsara Spark, and Samsara Beyond. Samsara's forums create a space where the industry can connect, share their most pressing challenges, exchange ideas, and spark innovation. These moments drive real-world outcomes and operational excellence. Another popular program, Samsara Professional Credentials, celebrates the expertise of individuals who complete tailored learning experiences through the Samsara Academy. Samsara is proud to help the industry solve complex challenges with technology and community. Article content 'With all the changes AI is bringing to physical operations, the partnership between industry leaders and technology innovators has never been more important,' said Kiren Sekar, Chief Product Officer at Samsara. 'Our advisory board isn't just about adapting to change, but actively shaping the future of this industry and making a lasting impact, together.' Article content Samsara (NYSE: IOT) is the pioneer of the Connected Operations ® Platform, which enables organizations that depend on physical operations to harness Internet of Things (IoT) data to develop actionable insights and improve their operations. With tens of thousands of customers across North America and Europe, Samsara is a proud technology partner to the people who keep our global economy running, including the world's leading organizations across construction, transportation and warehousing, field services, manufacturing, retail, logistics, and the public sector. The company's mission is to increase the safety, efficiency, and sustainability of the operations that power the global economy. Article content Article content Article content
Globe and Mail
36 minutes ago
- Globe and Mail
Candel Therapeutics Appoints Charles Schoch as Chief Financial Officer
NEEDHAM, Mass., June 23, 2025 (GLOBE NEWSWIRE) -- Candel Therapeutics, Inc. (Candel or the Company) (Nasdaq: CADL), a clinical-stage biopharmaceutical company focused on developing multimodal biological immunotherapies to help patients fight cancer, today announced the appointment of Charles Schoch as Chief Financial Officer (CFO). Mr. Schoch, who has served as interim CFO of Candel since January 2024, will transition to the CFO role permanently, effective immediately. 'Charles has demonstrated exceptional financial and organizational leadership during his tenure as interim CFO,' said Paul Peter Tak, M.D., Ph.D., FMedSci, President and Chief Executive Officer of Candel. 'He has effectively supported our strategic priorities in a complex market environment while maintaining disciplined capital management. His deep understanding of our business will continue to be instrumental as we advance our clinical pipeline, prepare for our Biologics License Application submission for CAN-2409 in localized prostate cancer, and execute on our near- and long-term corporate goals.' Since joining Candel in November 2021, Mr. Schoch has served in various financial reporting and accounting positions of increasing responsibility, most recently as VP of Finance and Corporate Controller, before being named interim CFO in January 2024. In his interim CFO role, Mr. Schoch developed significant investment banking relationships and has led the company through engagements with top-tier institutional investors, culminating in a previously-announced capital raise with net proceeds of approximately $86 million following the disclosure of positive results in the phase 3 clinical trial of CAN-2409 in localized prostate cancer in December 2024. In January 2025, he was promoted to Senior VP. During his time at Candel, Mr. Schoch has built a high-performing finance function that oversees Candel's financial close process, internal controls, SEC reporting, financial planning, procurement, payroll, and treasury operations. Mr. Schoch has also worked closely with Candel's executive leadership team on investor relations, business development, and financing initiatives. Prior to joining Candel, Mr. Schoch served as Corporate Controller at Corbus Pharmaceuticals from 2019 to 2021. Before Corbus, he spent seven years in PwC's Health Industry assurance practice where he served a diverse group of audit clients, ranging from pre-IPO to multinational public companies within the life sciences sector. Earlier in his career, Mr. Schoch worked for several Third Rock Venture portfolio companies as a financial and operational consultant. Mr. Schoch holds an M.B.A. and M.S.A. from Northeastern University and a B.S. in business administration with a concentration in finance from Elon University. 'I am honored to continue serving in this role and excited about the opportunities that lie ahead for Candel,' commented Mr. Schoch. 'Our strong financial foundation and disciplined approach to capital allocation and value creation position us well for sustainable growth. As we advance our promising clinical pipeline and prepare for key milestones, my focus remains on maintaining financial stability while strategically investing in our future. I look forward to working with our talented team on our goals of driving value for our stakeholders and ultimately helping to deliver clinically meaningful solutions to cancer patients in need.' About Candel Therapeutics Candel is a clinical-stage biopharmaceutical company focused on developing off-the-shelf multimodal biological immunotherapies that elicit an individualized, systemic anti-tumor immune response to help patients fight cancer. Candel has established two clinical-stage multimodal biological immunotherapy platforms based on novel, genetically modified adenovirus and herpes simplex virus (HSV) gene constructs, respectively. CAN-2409 is the lead product candidate from the adenovirus platform. The Company recently completed successful phase 2a clinical trials of CAN-2409 in non-small cell lung cancer (NSCLC) and pancreatic ductal adenocarcinoma (PDAC), and a pivotal phase 3 clinical trial of CAN-2409 in localized prostate cancer, conducted under a Special Protocol Assessment (SPA) agreed with the U.S. Food and Drug Administration (FDA). CAN-2409 plus prodrug (valacyclovir) has been granted Fast Track Designation by the FDA for the treatment of PDAC, stage III/IV NSCLC in patients who are resistant to first line PD-(L)1 inhibitor therapy and who do not have activating molecular driver mutations or have progressed on directed molecular therapy and localized primary prostate cancer. The FDA most recently also granted Regenerative Medicine Advanced Therapy (RMAT) Designation to CAN-2409 for the treatment of newly diagnosed localized prostate cancer in patients with intermediate-to-high-risk disease and Orphan Drug Designation to CAN-2409 for the treatment of PDAC. CAN-3110 is the lead product candidate from the HSV platform and is currently in an ongoing phase 1b clinical trial in recurrent high-grade glioma (rHGG). Initial results were published in Nature and CAN-3110 received Fast Track Designation and Orphan Drug Designation from the FDA. Finally, Candel's enLIGHTEN™ Discovery Platform is a systematic, iterative HSV-based discovery platform leveraging human biology and advanced analytics to create new viral immunotherapies for solid tumors. For more information about Candel, visit: Forward-Looking Statements This press release includes certain disclosures that contain 'forward-looking statements,' within the meaning of the Private Securities Litigation Reform Act of 1995, as amended, including, without limitation, express or implied statements regarding the timing and advancement of current and future development programs, expectations regarding the submission of the BLA for CAN-2409 in intermediate-to-high-risk localized prostate cancer; and expectations regarding the therapeutic benefit of the Company's platforms, including the ability of its platforms to improve overall survival and/or disease-free survival of patients living with difficult to treat, solid tumors. The words 'may,' 'will,' 'could,' 'would,' 'should,' 'expect,' 'plan,' 'anticipate,' 'intend,' 'believe,' 'estimate,' 'predict,' 'project,' 'potential,' 'continue,' 'target' and similar expressions are intended to identify forward-looking statements, although not all forward-looking statements contain these identifying words. Any forward-looking statements in this press release are based on management's current expectations and beliefs and are subject to a number of risks, uncertainties and important factors that may cause actual events or results to differ materially from those expressed or implied by any forward-looking statements contained in this press release, including, without limitation, those risks and uncertainties related to the timing and advancement of development programs; expectations regarding the therapeutic benefit of the Company's programs; that final data from the Company's preclinical studies and completed clinical trials may differ materially from reported interim data from ongoing studies and trials; the Company's ability to efficiently discover and develop product candidates; the Company's ability to obtain and maintain regulatory approval of product candidates; the Company's ability to maintain its intellectual property; the implementation of the Company's business model, including strategic plans for the Company's business and product candidates; and other risks identified in the Company's filings with the U.S. Securities and Exchange Commission (SEC), including the Company's most recent Annual Report on Form 10-K and Quarterly Report on Form 10-Q for the quarter ended March 31, 2025, each as filed with the SEC and any subsequent filings with the SEC. The Company cautions you not to place undue reliance on any forward-looking statements, which speak only as of the date they are made. The Company disclaims any obligation to publicly update or revise any such statements to reflect any change in expectations or in events, conditions, or circumstances on which any such statements may be based, or that may affect the likelihood that actual results will differ from those set forth in the forward-looking statements. Any forward-looking statements contained in this press release represent the Company's views only as of the date hereof and should not be relied upon as representing its views as of any subsequent date. Investor Contact: Theodore Jenkins VP, Investor Relations and Business Development Candel Therapeutics, Inc. tjenkins@
Globe and Mail
an hour ago
- Globe and Mail
Liberty Defense is Pleased to Announce that it has Received a Multi Unit HEXWAVE Order to Screen Aviation Workers for a growing US International Airport
WILMINGTON, Mass., June 17, 2025 — Liberty Defense Holdings Ltd. (' Liberty ' or the ' Company ') (TSXV:SCAN, OTCQB:LDDFF), a leading technology provider of AI-based next generation detection solutions for concealed weapons and threats, is pleased to announce that its HEXWAVE system was selected by another US International Airport to screen aviation workers as part of the new TSA Mandate on Employee Screening. In April 2023, a mandate was issued requiring U.S. airports to adopt physical screening procedures for employees with access to secure-side areas of the airport. The mandate was further reinforced by a U.S. Court of Appeals decision denying airports the ability to delay the screening process. All major airports will be required to deploy screening technology by April 2026 to meet the 100% screening mandate. To implement screening for aviation workers, airports will need technologies that provide a broad range of threat detection that can meet the current screening requirements and those mandated for the future. The HEXWAVE was selected by the airport following a competitive tender process. The order was received through our partner and distributor Point Security Inc., a recognized leader in the US security screening industry for sales, and more importantly excellent service and support. HEXWAVE uses millimeter wave, advanced 3D imaging and AI to detect concealed metallic and non-metallic threats and other prohibited items. The system allows for rapid, automated screening using a high-throughput, contactless, walkthrough portal to detect liquid, powder and plastic explosives, 3D printed ghost guns and other contraband. 'We're honored to receive this award and to expand our footprint at U.S. airports through the Aviation Worker Screening Program,' said Liberty CEO Bill Frain. 'HEXWAVE has demonstrated its effectiveness across airports of all sizes. Its mobility and flexible configurations make it a strong fit for facilities working to meet the airports screening requirements. Ultimately, our mission is to enhance airport security by detecting both metallic and non-metallic threats—something millimeter wave technology does exceptionally well. We believe HEXWAVE is well positioned to become the preferred solution nationwide as airports implement this mandate.' For updates and news, please visit to subscribe to email alerts or follow Liberty Defense on social channels. On Behalf of Liberty Defense Bill Frain CEO & Director About Liberty Defense Liberty Defense (TSXV:SCAN, OTCQB:LDDFF) provides multi-technology security solutions for concealed weapons detection in high-volume foot traffic areas and locations requiring enhanced security such as airports, stadiums, schools and more. Liberty's HEXWAVE product, for which the company has secured an exclusive license from Massachusetts Institute of Technology (MIT), as well as a technology transfer agreement for patents related to active 3D radar imaging technology, provides discrete, modular and scalable protection to provide layered, stand-off detection capability of metallic and non-metallic weapons. Liberty has also recently licensed the millimeter wave-based, High-Definition Advanced Imaging Technology (HD-AIT) body scanner and shoe scanner technologies as part of its technology portfolio. Liberty is committed to protecting communities and preserving peace of mind through superior security detection solutions. Learn more: For further information about Liberty, please contact: Jay Adelaar Senior Vice President of Capital Markets, Liberty Defense 604-809-2500 jay@ For sales information, please contact: Ian McNaughton Senior Director Business Development, Liberty Defense 613-292-3669 imcnaughton@ FORWARD-LOOKING STATEMENTS When used in this press release, the words 'estimate', 'project', 'belief', 'anticipate', 'intend', 'expect', 'plan', 'predict', 'may' or 'should' and the negative of these words or such variations thereon or comparable terminology are intended to identify forward-looking statements and information. Although Liberty believes, in light of the experience of their respective officers and directors, current conditions and expected future developments and other factors that have been considered appropriate, that the expectations reflected in the forward-looking statements and information in this press release are reasonable, undue reliance should not be placed on them because the parties can give no assurance that such statements will prove to be correct. Such statements and information reflect the current view of Liberty. There are risks and uncertainties that may cause actual results to differ materially from those contemplated in those forward-looking statements and information. By their nature, forward-looking statements involve known and unknown risks, uncertainties and other factors which may cause our actual results, performance or achievements, or other future events, to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statements. There are a number of important factors that could cause Liberty's actual results to differ materially from those indicated or implied by forward-looking statements and information. Such factors include, among others: currency fluctuations; limited business history of the parties; disruptions or changes in the credit or security markets; results of operation activities and development of projects; project cost overruns or unanticipated costs and expenses; and general development, market and industry conditions. The parties undertake no obligation to comment on analyses, expectations or statements made by third parties in respect of their securities or their respective financial or operating results (as applicable). Liberty cautions that the foregoing list of material factors is not exhaustive. When relying on Liberty's forward-looking statements and information to make decisions, investors and others should carefully consider the foregoing factors and other uncertainties and potential events. Liberty has assumed that the material factors referred to in the previous paragraph will not cause such forward-looking statements and information to differ materially from actual results or events. However, the list of these factors is not exhaustive and is subject to change and there can be no assurance that such assumptions will reflect the actual outcome of such items or factors. The forward-looking information contained in this press release represents the expectations of Liberty as of the date of this press release and, accordingly, are subject to change after such date. Liberty does not undertake to update this information at any particular time except as required in accordance with applicable laws. Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this press release. Featured Image @ Freepik Read more investing news on to the PressReach RSS feeds:
